Literature DB >> 15349877

Ataxin-7 aggregation and ubiquitination in infantile SCA7 with 180 CAG repeats.

Olaf Ansorge1, Paola Giunti, Andrej Michalik, Christine Van Broeckhoven, Brian Harding, Nicholas Wood, Francesco Scaravilli.   

Abstract

Extremely long (>150) CAG repeats are often used to create models of polyglutamine diseases yet are very rare in humans where they manifest as pediatric multisystem syndromes of little specificity. Here, we describe an infant with 180 CAG repeats in the spinocerebellar ataxia type 7 gene and focus on systemic ataxin-7 aggregation. This was found in many organs, including the cardiovascular system. In the brain, the hippocampus emerged as a principal site of ataxin-7 aggregation without cell loss. We note differential ubiquitination of aggregates and discuss how this may relate to selective vulnerability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15349877     DOI: 10.1002/ana.20230

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Large pathogenic expansions in the SCA2 and SCA7 genes can be detected by fluorescent repeat-primed polymerase chain reaction assay.

Authors:  Claudia Cagnoli; Giovanni Stevanin; Chiara Michielotto; Giovanni Gerbino Promis; Alessandro Brussino; Patrizia Pappi; Alexandra Durr; Elisa Dragone; Michelle Viemont; Cinzia Gellera; Alexis Brice; Nicola Migone; Alfredo Brusco
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

Review 2.  Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.

Authors:  Anna Niewiadomska-Cimicka; Yvon Trottier
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

3.  Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex.

Authors:  Hui Yang; Shuai Liu; Wen-Tian He; Jian Zhao; Lei-Lei Jiang; Hong-Yu Hu
Journal:  J Biol Chem       Date:  2015-07-20       Impact factor: 5.157

4.  Spinocerebellar ataxia type 7: clinical course, phenotype-genotype correlations, and neuropathology.

Authors:  Laura C Horton; Matthew P Frosch; Mark G Vangel; Carol Weigel-DiFranco; Eliot L Berson; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2013-04       Impact factor: 3.847

5.  LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model.

Authors:  Javier Alegre-Abarrategui; Helen Christian; Michele M P Lufino; Ruxandra Mutihac; Lara Lourenço Venda; Olaf Ansorge; Richard Wade-Martins
Journal:  Hum Mol Genet       Date:  2009-07-29       Impact factor: 6.150

6.  Association with proteasome determines pathogenic threshold of polyglutamine expansion diseases.

Authors:  Meewhi Kim; Ilya Bezprozvanny
Journal:  Biochem Biophys Res Commun       Date:  2020-12-25       Impact factor: 3.575

7.  Spinocerebellar ataxia type 7: Report of an Indian family.

Authors:  Gurusidheshwar M Wali
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

8.  Pathogenic polyglutamine expansion length correlates with polarity of the flanking sequences.

Authors:  Meewhi Kim
Journal:  Mol Neurodegener       Date:  2014-11-06       Impact factor: 14.195

9.  Metabolic and Organelle Morphology Defects in Mice and Human Patients Define Spinocerebellar Ataxia Type 7 as a Mitochondrial Disease.

Authors:  Jacqueline M Ward; Colleen A Stoyas; Pawel M Switonski; Farid Ichou; Weiwei Fan; Brett Collins; Christopher E Wall; Isaac Adanyeguh; Chenchen Niu; Bryce L Sopher; Chizuru Kinoshita; Richard S Morrison; Alexandra Durr; Alysson R Muotri; Ronald M Evans; Fanny Mochel; Albert R La Spada
Journal:  Cell Rep       Date:  2019-01-29       Impact factor: 9.423

Review 10.  Juvenile Huntington's Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data.

Authors:  Karolina Świtońska-Kurkowska; Bart Krist; Joanna Delimata; Maciej Figiel
Journal:  Front Cell Dev Biol       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.